Project Grant R01DA066717
- Federal Project Grant Award Summary Boston College received a $155,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 1, 2026, through April 30, 2028. The award funds research examining the effects of state recreational cannabis legalization on disparities in prenatal substance use, including cannabis, tobacco, and alcohol consumption among pregnant women. The research will utilize the...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $183,681 to Michigan State University (in partnership with Henry Ford Health) on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a patient-engaged technology-based intervention reducing prenatal cannabis use. The research deliverables include the development of an Electronic Screening and Brief Intervention (ESBI) platform combined with...
- Federal Project Grant Award Summary Cambridge Health Alliance (CHA), a Harvard Medical School teaching affiliate based in East Cambridge, Massachusetts, received a $776,604 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 15, 2026. The grant funds a convergent parallel mixed methods research initiative examining the impact of recreational cannabis legalization (RCL) on cannabis, nicotine, and alcohol...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $730,649 to the University of California, San Diego, effective May 1, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project investigates the acute effects of cannabis use on parenting behaviors among routine cannabis users with young children (ages 3-6 years). The deliverables include a comprehensive longitudinal study...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary Boston University Medical Campus received a $732,747 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2026, with completion anticipated by March 31, 2031. The grant supports research quantifying health effects of cannabis use and cannabis use disorder (CUD) on geriatric syndromes and HIV treatment outcomes among aging people living with HIV (PWH). The research...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $759,210 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective April 1, 2026, with a completion date of January 31, 2031. This grant supports translational research investigating the impact of prenatal tetrahydrocannabinol (THC) exposure on offspring neurodevelopment and behavioral outcomes. The research leverages a...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant, effective March 1, 2026, through December 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award funds a longitudinal neuroimaging research initiative designed to delineate developmental windows of vulnerability to cannabis exposure and establish causal relationships between cannabis use, brain...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
Boston College has been awarded $372,936 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal research study examining the effects of recreational cannabis legalization policies on prenatal cannabis use and associated maternal and child health outcomes. The project, awarded June 15, 2026 with completion targeted for April 30, 2030, will deliver comprehensive epidemiological research utilizing a novel data linkage between Maine's Pregnancy Risk Assessment Monitoring System cohorts (2016-2023) and state health claims databases. The research will provide empirical analysis covering approximately 6,307 pregnant women and their children, tracking cannabis, tobacco, and alcohol use patterns across a six-year window from two years prior to conception through three years postpartum (2014-2026). The research deliverables will include rigorous evaluation of state and county-level recreational cannabis policy effects on substance use and health outcomes, taking advantage of Maine's natural policy experiment whereby legalization occurred in January 2017 with staggered retail sales implementation across counties beginning October 2020. The study will generate evidence-based findings regarding policy spillover effects on other substances, birth outcomes, maternal and child health trajectories, provider assessment practices, and variation in policy effects across individual and area-level demographic and socioeconomic factors. These research products will address significant knowledge gaps in understanding cannabis legalization's real-world health impacts during a critical period of rapid policy evolution across 24 states and the District of Columbia.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $372.9k | 6/10/26 |